Search Results: IdentityIQ-Engineer Sample Questions Answers 🛅 Latest IdentityIQ-Engineer Mock Test 🔒 IdentityIQ-Engineer Exam PDF 🔱 ▷ www.pdfvce.com ◁ is best website to obtain “ IdentityIQ-Engineer ” for free download 🐴Sample IdentityIQ-Engineer Questions
The Christopher Project Report to the Myotonic Dystrophy Community is Now Available
The results of the Christopher Project have been published in a comprehensive, 80-page report. The creation of “The Christopher Project Report to the Myotonic Dystrophy Community” was supported by several…
Tags: Research
Simply Stated: What is Myasthenia Gravis?
Myasthenia gravis (MG) is an autoimmune disease, which is a disease that occurs when the immune system goes awry and produces antibodies that attack the body’s own tissues. Normally, antibodies…
Tags: Drug Approval, Research, Simply Stated
Q&A With SSSI-MDA Fellow and Researcher Adam Bittel
Adam Bittel, PT, DPT, PhD, a postdoctoral fellow at Children’s National Medical Center in Washington, DC, was awarded the 2019 SSSI-MDA Fellowship Award. The award, co-sponsored by Strength, Science & Stories of…
Tags: Grants, Research, Staying Active
10 Facts About FSHD — and a Reason to Smile
An older gentleman came up to me once. I had just been on TV for the Jerry Lewis MDA Labor Day Telethon talking about how facioscalpulohumeral muscular dystrophy (FSHD) affects…
Tags: Ambassadors, Community, Genetic Testing
Researcher with FSHD Awarded MDA Funding to Discover New Therapies for the Disease
Dr. Justin Cohen Like many pre-medical students, Justin Cohen discovered along the way that what he really liked was research. However, unlike others who exchange the stethoscope for a microscope,…
MDA Awards Venture Philanthropy Funding to Locana to Develop Novel Treatment for DM
Today, MDA and Locana, a leading RNA-targeting gene therapy company, announced the award of an MDA Venture Philanthropy (MVP) grant totaling $550,000 to advance Locana’s development program for myotonic dystrophy…
Tags: Drug Development, Gene Therapy, Grants, Research
FDA Approves PTC Therapeutics’ Emflaza for the Treatment of DMD in Patients Between 2 and 5 Years Old
On June 7, the U.S. Food and Drug Administration (FDA) approved Emflaza (deflazacort) to expand its labeling to include patients with Duchenne muscular dystrophy (DMD) who are between 2 and…
Tags: Drug Approval, Newborn Screening, Research
Congress is Considering a Law to Strengthen Newborn Screening: Help MDA Promote its Passage
On May 2, Reps. Lucille Roybal-Allard (CA-40), Mike Simpson (ID-02), Katherine Clark (MA-05), and Jaime Herrera-Beutler (WA-03) introduced the Newborn Screening Saves Lives Reauthorization Act of 2019, a key piece…
Clinical Trial Alert: Alexion Pharmaceuticals Seeks Participants for a Phase 3 Pediatric Myasthenia Gravis Study
Researchers at Alexion Pharmaceuticals are looking for children with generalized myasthenia gravis (gMG) to participate in an open-label Phase 3 study. The goal of the study is to evaluate the…
Clinical Trial Alert: Biogen Seeks Participants for a Phase 3 SOD1-ALS Study
Researchers at Biogen are looking for participants with amyotrophic lateral sclerosis (ALS) to participate in the VALOR Phase 3 study designed to help researchers evaluate the effects of BIIB067 on…